GLENMARK PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,080 INR | +0.87% |
|
+1.92% | +26.51% |
| 02:12pm | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
| Apr. 01 | Glenmark Pharmaceuticals Limited Announces Board Changes | CI |
Chart calendar Glenmark Pharmaceuticals Limited
7abdc3c821eec6bf9e7bf047.t22Ecalhfvu_dE0lQ6zOk1DLJ0AE1F6JyoAO3NbqNZ0.5QfRN8QET67YBCB2Keqc5yX7dnFw4zLklblliKG6X9z5GsFA4i8ytf45AA~4f70b661d3923dddcdc544d37a45ce29
Upcoming events on Glenmark Pharmaceuticals Limited
Past events on Glenmark Pharmaceuticals Limited
| 2024-02-28 | Investec Promoter & Founder Conference |
| 2024-02-21 | Kotak Chasing Growth Conference |
| 2024-02-15 10:00 pm | Q3 2024 Earnings Call |
| 2024-02-14 08:14 am | Q3 2024 Earnings Release |
| 2023-11-22 | JM Financial India Conference |
| 2023-11-14 10:00 pm | Q2 2024 Earnings Call |
| 2023-11-10 08:27 am | Q2 2024 Earnings Release |
| 2023-09-29 04:30 am | Annual General Meeting |
| 2023-09-26 | Kotak Healthcare Conference |
| 2023-09-17 | Ex-dividend day for final dividend |
| 2023-08-14 12:00 am | Q1 2024 Earnings Call |
| 2023-08-11 08:31 am | Q1 2024 Earnings Release |
| 2023-05-22 12:00 am | Q4 2023 Earnings Call |
| 2023-05-19 09:30 am | Q4 2023 Earnings Release |
| 2023-02-12 11:00 pm | Q3 2023 Earnings Call |
| 2023-02-10 09:17 am | Q3 2023 Earnings Release |
| 2022-11-13 11:00 pm | Interim 2023 Earnings Call |
| 2022-11-11 08:47 am | Interim 2023 Earnings Release |
| 2022-09-27 04:30 am | Annual General Meeting |
| 2022-09-11 | Ex-dividend day for final dividend |
Past dividends on Glenmark Pharmaceuticals Limited
| 2023-09-17 | Annual 2.5 INR |
| 2022-09-11 | Annual 2.5 INR |
| 2021-09-07 | Annual 2.5 INR |
| 2020-09-16 | Annual 2.5 INR |
| 2019-09-18 | Annual 2 INR |
| 2018-09-18 | Annual 2 INR |
| 2017-09-19 | Annual 2 INR |
| 2016-08-02 | Annual 2 INR |
| 2015-09-09 | Annual 2 INR |
| 2014-07-09 | Annual 2 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 98 655 99 435 -0.78% | 106 410 105 799 0.58% | 109 439 110 524 -0.98% | 123 409 121 943 1.2% | 129 901 129 386 0.4% | 121 436 |
|
EBITDA Million INR | Released Forecast Spread | 17 939 16 995 5.55% | 16 981 16 170 5.02% | 20 844 20 659 0.9% | 23 203 23 221 -0.08% | 22 784 22 721 0.27% | 12 869 |
|
EBIT Million INR | Released Forecast Spread | 14 254 13 423 6.19% | 12 809 12 227 4.76% | 16 408 16 275 0.82% | 18 336 18 300 0.2% | 16 671 16 771 -0.6% | 7 400 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 12 580 12 533 0.37% | 10 961 10 286 6.56% | 13 825 13 415 3.06% | 14 412 16 296 -11.56% | 8 685 17 030 -49% | -206 |
|
Net income Million INR | Released Forecast Spread | 8 917 9 061 -1.59% | 7 760 7 287 6.49% | 9 701 9 378 3.44% | 9 936 11 391 -12.77% | 2 972 9 929 -70.06% | 33 363 |
|
EPS INR | Released Forecast Spread | 31,6 33,5 -5.64% | 27,5 25,5 7.77% | 34,4 32,3 6.39% | 33,4 38,3 -12.86% | 10,5 35,7 -70.51% | 25,4 |
| Announcement Date | 29/05/19 | 26/06/20 | 28/05/21 | 27/05/22 | 19/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 28 599 28 495 0.37% | 29 649 30 310 -2.18% | 31 474 30 782 2.25% | 31 734 30 361 4.52% | 30 191 29 906 0.95% | 27 773 28 714 -3.28% | 33 752 31 227 8.09% | 34 639 32 928 5.2% | 33 737 33 286 1.36% | 34 016 31 763 7.09% | 35 822 | 34 919 | 33 001 |
|
EBITDA Million INR | Released Forecast Spread | 5 234 5 314 -1.51% | 5 736 6 062 -5.38% | 5 902 5 707 3.41% | 5 148 6 251 -17.65% | 4 634 5 289 -12.38% | 4 726 4 714 0.26% | 6 216 5 551 11.99% | 6 202 6 041 2.68% | 6 050 6 080 -0.51% | 5 866 5 740 2.21% | 6 716 | 5 905 | 5 152 |
|
EBIT Million INR | Released Forecast Spread | 4 124 4 216 -2.2% | 4 605 4 545 1.33% | 4 670 4 739 -1.46% | 3 958 4 808 -17.67% | 3 319 3 774 -12.07% | 4 108 3 654 12.42% | 4 659 3 968 17.4% | 4 580 4 766 -3.91% | 4 584 4 519 1.46% | 4 320 4 607 -6.24% | 5 137 | 3 989 | 3 075 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 375 3 584 -5.83% | 4 436 3 964 11.9% | 3 850 3 951 -2.57% | 3 430 4 056 -15.41% | 2 697 3 336 -19.15% | 4 080 2 610 56.33% | 4 802 4 259 12.75% | 4 710 3 655 28.88% | -4 908 4 041 -221.45% | 3 334 3 686 -9.55% | 3 205 | 4 099 | 2 164 |
|
Net income Million INR | Released Forecast Spread | 2 339 2 462 -5.01% | 3 065 2 894 5.91% | 2 577 2 752 -6.38% | 2 219 2 975 -25.41% | 1 726 1 994 -13.44% | 1 925 1 769 8.82% | 2 604 2 572 1.25% | 2 726 2 428 12.29% | -4 283 2 599 -264.81% | 1 499 2 487 -39.7% | 2 574 | 2 451 | 2 243 |
| Announcement Date | 28/05/21 | 13/08/21 | 12/11/21 | 11/02/22 | 27/05/22 | 10/08/22 | 11/11/22 | 10/02/23 | 19/05/23 | 11/08/23 | - | - | - |
More events
Past sector events for Glenmark Pharmaceuticals Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GLENMARK Stock
- Calendar Glenmark Pharmaceuticals Limited
